Protozoan parasites undergo developmental responses to adapt to the different environments encountered within their mammalian host, or during passage through their arthropod vectors^[@R2]-[@R4]^. As a preparation for transmission, specialized developmental forms are often generated to promote survival when ingested by a biting insect^[@R1],[@R5]^. The abundance of these transmission stages can fluctuate during the course of a blood parasitaemia as can the abundance of the proliferative forms that sustain the infection. The balance of these different cell types determines the within-host dynamics of a parasite, ensuring that the population can maximize its longevity within a host, but also optimize its capacity for spread to new hosts^[@R6]-[@R8]^.

African trypanosomes, *Trypanosoma brucei* spp., are extracellular parasites responsible for Human African Trypanosomiasis (HAT) and the livestock disease 'nagana'^[@R9]^. In the bloodstream, trypanosomes proliferate as morphologically 'slender' forms that evade host immunity by antigenic variation, generating characteristic waves of infection. As each wave of parasitaemia ascends, slender forms stop proliferating and undergo morphological and molecular transformation to stumpy forms, the parasite's transmission stage^[@R10],[@R11]^. This differentiation is parasite density-dependent^[@R12]^, resembling quorum-sensing systems common in microbial communities^[@R13]^. However, the differentiation-inducing factor SIF ('stumpy induction factor') is unidentified and, whilst some inhibitors of development have been identified^[@R14]-[@R16]^, the signal-response pathway that promotes stumpy formation is uncharacterised. Moreover, density-sensing is reduced in laboratory-adapted 'monomorphic' parasite strains^[@R16]^ although they can undergo cell-cycle arrest and the limited expression of some stumpy-specific genes when exposed to cell permeable analogues of cAMP or AMP^[@R16]-[@R18]^. This is distinct from cAMP-based signaling since only hydrolysable cAMP drives development, which is metabolized to AMP in the parasite^[@R17],[@R19]^.

The availability of monomorphic parasite RNAi libraries capable of tetracycline-inducible gene silencing on a genome-wide scale^[@R20]^ and their ability to respond to hydrolysable-cAMP and AMP analogues allowed us to investigate genes that regulate stumpy formation. Thus, an RNAi library population of 2.5 ×10^7^ cells (maintained with \~5 fold genome coverage) was selected with 100 μM pCPTcAMP or 10 μM 8-pCPT-2′-O-Me-5′-AMP^[@R17]^ in several replicate flasks, RNAi being induced, or not, with tetracycline ([Figure 1a](#F1){ref-type="fig"}). Uninduced populations underwent division arrest and eventual death over 5 days ([Figure 1b](#F1){ref-type="fig"}), whereas, three pCPTcAMP-selected and five 8-pCPT-2′-O-Me-5′-AMP-selected populations outgrew in the RNAi-induced populations, these being subject to DNA isolation and RNAi insert amplification ([Figure 1b](#F1){ref-type="fig"}; Supp. Figure 1a). The resulting amplicon profiles varied in intensity but there was remarkable similarity between independently-selected populations under each regimen (Supp. Figure 1a). To analyse the amplicon complexity in depth, populations from each screen were subjected to Ion torrent™ sequencing^[@R21]^. Reads were aligned to the *T. brucei* TREU 927/4 reference genome ([www.genedb.org](http://www.genedb.org)), identifying 43 genes potentially targeted in either screen ([Figure 1c](#F1){ref-type="fig"}; [Supp. Dataset 1](#SD3){ref-type="supplementary-material"}; [Supp. Table 1](#SD6){ref-type="supplementary-material"}). Twelve genes were common to both screens, 5 were 8-pCPT-2′-O-Me-5′-AMP-specific and 26 were pCPTcAMP-specific, likely reflecting the observed complexity in each amplicon population ([Supp. Table 1](#SD6){ref-type="supplementary-material"}). Analysing the reads for genome alignment and for the presence of the appropriate RNAi library primer flanks refined the list to 27-30 distinct gene targets ([Supp. Table 2](#SD7){ref-type="supplementary-material"}, [Supp. Table 3](#SD8){ref-type="supplementary-material"}, Supp. Figure 1b, [Supp. Dataset 2](#SD4){ref-type="supplementary-material"}).

As expected genes encoding enzymes involved in cAMP/AMP-analogue processing and cellular purine balance were identified, with six selected RNAi targets predicted to alter intracellular AMP levels (Supp. Figure 2a). For example, 8-pCPT-2′-O-Me-5′-AMP is converted to 8-pCPT-2′-O-Me-5′-adenosine in culture medium^[@R17]^, such that RNAi against adenosine kinase would prevent the conversion of the transported pCPT-adenosine analogue to its AMP equivalent^[@R22]^ (Supp. Figure 2a). Similarly depletion of adenylosuccinate synthetase (*ADSS*) and adenylosuccinate lyase (*ADSL*) reduce the conversion of IMP to AMP, potentially counteracting the effect of the membrane permeable cAMP or AMP analogs. The identified adenylate kinase, GMP synthase and IMP dehydrogenase targets are also predicted to rebalance purine levels within the parasites.

Signal transduction pathway genes were also unambiguously targeted by RNAi in the selected populations ([Supp. Table 2](#SD7){ref-type="supplementary-material"}; [Supp. Table 3](#SD8){ref-type="supplementary-material"}; [Supp. Datasets 2](#SD4){ref-type="supplementary-material"} and [3](#SD2){ref-type="supplementary-material"}). Potentially linking AMP balance to downstream cellular effects, an AMPK/SNF1/KIN11 homologue target (Tb927.3.4560) was identified, as was a MEK kinase (Tb927.2.2720), and predicted cell-cycle regulators of the NEK kinase (Tb927.10.5930/40/50; these three tandem genes being indistinguishable by RNAi phenotyping) and Dyrk/YAK kinase (Tb927.10.15020) families, the latter being required for cellular quiescence (G0) in yeast^[@R23]^ and *Dictyostelium^[@R24]^*. A dual-specificity phosphatase (Tb927.7.7160) and members of the protein phosphatase 1 gene family (*PP1-4, PP1-5, PP1-6*^[@R25]^; Tb927.4.3620/30/40) were also selected, genes whose knock-down generates only limited cell growth defects in proliferative procyclic forms^[@R25]^. Finally regulatory and effector molecules were represented by the *RBP7* RNA binding proteins (*RBP7A* and *RBP7B*, Tb927.10.12090/12100, indistinguishable by RNAi), whereas a number of hypothetical proteins with no detectable homologies to any gene were also identified. Overall, this suggested that representatives at many stages in the pCPTcAMP/8-pCPT-2′-O-Me-5′-AMP response pathway had been selected, from signal processing, through signal transduction to regulatory effector molecules.

To validate the identified genes, independent monomorphic and pleomorphic cell lines were initially generated targeting 12 discrete members ([Supp. Table2](#SD7){ref-type="supplementary-material"}). Nine genes were analysed in detail (Supp. Figures 2b, c), these representing different steps ('signal processing', 'signal transduction', 'effector molecules') in the predicted signal response pathway, and two hypothetical proteins (*HYP1*, Tb927.11.6600; *HYP2,* Tb927.9.4080) of unknown function, although *HYP2* has a DksA zinc finger motif involved in prokaryotic rRNA transcriptional responses to nutritional status and quorum sensing. Several generated a growth inhibition when targeted by RNAi indicating roles in other important cellular processes (*PP1, HYP1, ADSL*, *ADSS;* [Supp. Table 2](#SD7){ref-type="supplementary-material"}; Supp. Figure 2b, 2c), although for *ADSS* this was alleviated in monomorphs by pCPTcAMP, likely due to the restoration of the purine balance by the analog (Supp. Figure 2c). Several targeted genes showed evidence of increased resistance to pCPTcAMP-mediated growth inhibition validating their selection *in vitro* (*PP1, NEK*, *YAK*, *RBP7*A/B, *HYP 2, DS-PHOS*; Supp. Figure 2b).

To analyse the physiological relevance of the identified genes in developmental quorum-sensing, nine pleomorphic RNAi cell lines were investigated for their response to the SIF signal *in vivo.* [Figure 2](#F2){ref-type="fig"} shows that the parental AnTat 1.1 90:13 line generated a highly-enriched population of arrested stumpy forms, these accumulating from day 4 onwards ([Figure 2a](#F2){ref-type="fig"}). For *ADSL* and *ADSS* parasitaemias were strongly suppressed for at least 5 days, matching their growth characteristics *in vitro* (Supp. Figure 2c, 3). In contrast, all of the other target RNAi lines exhibited abrogated or delayed stumpy formation over 4-6 days, with mice requiring sacrifice at the exceptionally high parasitaemias generated in the case of *PP1*, *NEK*, *YAK* and *DS-PHOS* ([Figure 2a](#F2){ref-type="fig"}). The induced parasites also retained a slender morphology or showed delayed progression to stumpy morphology compared to the control or uninduced infections ([Figure 2b](#F2){ref-type="fig"} and Supp. Figure 4a). In two cases ('*RBP7′*, '*HYP1*′), the cell lines generated elevated growth when uninduced, reflecting leaky RNAi for these lines (Supp. Figure 4b). Such leaky RNAi would be positively selected for genes involved in density-dependent cell-cycle arrest. Confirming the reduction of stumpy formation in each cell line *in vivo*, cell-cycle analysis during the course of the parasitaemias revealed reduced accumulation of cells with a 1 kinetoplast and 1 nucleus (1K1N) configuration, indicating loss or a delay of the cell-cycle arrest in G1/G0 characteristic of stumpy forms ([Figure 3a](#F3){ref-type="fig"}). Detailed analysis of the molecular characteristics of the populations confirmed that the parasites showed reduced or delayed expression of the stumpy-specific surface protein PAD1^[@R26]^ (*PP1* depleted cells are shown in [Figure 3b](#F3){ref-type="fig"} and Supp. Figure 5a) as well as reduced mitochondrial elaboration (Supp. Figure 5b). As expected for a slender-enriched population, the *PP1*-depleted cells were less able to differentiate to procyclic forms after exposure to cis-aconitate (CCA), indicated by reduced procyclin expression ([Figure 3c](#F3){ref-type="fig"}; Supp. Fig. 5c; Supp. Figure 6a) and kinetoplast repositioning (Supp. Figure 6b). Hence, by the key parameters, RNAi targeting of genes predicted to operate at different steps in a signaling pathway prevented or delayed stumpy formation *in vivo*, confirming their involvement in physiological quorum sensing. With respect to an effector function, the overexpression of *RBP7B* (Tb927.10.12100) ([Figure 4a](#F4){ref-type="fig"}) promoted premature cell-cycle arrest ([Figure 4b, c](#F4){ref-type="fig"}; Supp. Figure 7) and increased capacity for differentiation to procyclic forms in pleomorphic lines ([Figure 4d](#F4){ref-type="fig"}) albeit incompletely in the population, similar to the *RBP6*-mediated regulation of development in tsetse forms^[@R27]^. Transcriptome analysis revealed few widespread changes in gene expression upon perturbed *RBP7* expression (Supp. Figure 8 and 9; [Supp. Dataset 4](#SD5){ref-type="supplementary-material"}), although RNA regulators and procyclin transcripts were elevated in *RBP7* over-expressing cells whilst histones were downregulated compared to *RBP7* depleted cells (Supp. Figure 9; [Supp. Data set 4](#SD5){ref-type="supplementary-material"}), consistent with their cell cycle arrest and differentiation competence.

By employing a stringent genome-wide *in vitro* selection, these experiments have provided a first identification of the molecules required to promote the development of trypanosome transmission stages in the mammalian bloodstream ([Supp. Table 2](#SD7){ref-type="supplementary-material"} and [Figure 4e](#F4){ref-type="fig"}). Although inhibitors of stumpy formation^[@R14]-[@R16]^ would not be identified in the screens, the reproducibility of the enriched amplicons in independent selections and the use of Ion Torrent™-based deep-sequencing indicates that many genes involved in the promotion of stumpy formation have been identified. Moreover, this set is significantly enriched for genes whose RNAi reduces differentiation to procyclic forms in monomorphic lines (*P*=0.0008 *X*^2^ test; Supp. Figure 10), indicating that monomorphs need to progress through a stumpy-like (quiescent) form to differentiate to procyclic forms. Although the use of membrane-permeable analogues prevents identification of the SIF receptor at the parasite surface, our results reveal that selecting resistance to AMP analogues identifies purine salvage enzymes, but also genes important in the physiological SIF signaling pathway ([Figure 4e](#F4){ref-type="fig"}). Interestingly, the *AMPK/SNF1/KIN11* homologue (Tb927.3.4560) is a potential AMP/ATP energy sensor that could inhibit *Tb*TORC4, whose activity is proposed to prevent stumpy formation^[@R16]^. Combined with the confirmation of downstream transduction components such as *PP1*, *NEK*, *YAK* kinase and a dual-specificity phosphatase our analyses reveal that QS-signaled production of stumpy forms in trypanosomes shares components with quiescence regulation in mammalian stem cells^[@R28]^ and the starvation responses and developmental transitions of unicellular eukaryotes^[@R29]^.

This assembly of the molecular regulators of quorum-sensing provides the first detailed catalogue of an environmental signaling pathway in trypanosomes, providing molecular insight into microbial sociality relevant to both virulence and transmission in a major eukaryotic pathogen. As drivers of the irreversible arrest of stumpy forms in the mammalian bloodstream these molecules also represent novel therapeutic targets via quorum sensing interference^[@R30]^, whose pharmacological activation would generate a stringent anti-virulence effect.

Methods {#S8}
=======

RNAi screens {#S9}
------------

The RNAi library was removed from liquid Nitrogen and added to 10% HMI-9 containing 2 μg/ml blasticidin and 1 μg/ml phleomycin to maintain transfectant selection. The library was divided into three cultures of 2.5×10^7^cells at 2.5×10^5^cells/ml and 1μg/ml tetracycline added to one to induce dsRNA. 24hours after induction two cultures were maintained at 5×10^7^cells at 2.5×10^5^cells/ml, to ensure full genome coverage, in medium containing 10μM 8pCPT-2-O'-Me-5′AMP or 100μM 8-(4-chlorophenylthio)-cAMP. DNA was harvested from the third culture without drug addition ("before experiment"; BE). Both treated cultures were divided into five smaller volumes (1×10^7^cells in each) for optimum growth conditions. Cell counts were made every 24hours using the Beckman Z2 coulter particle count & size analyser or haemocytometer as appropriate. Proliferating cultures were split to 2.5×10^5^cells/ml when necessary.

Tetracycline and 10 μM 8pCPT-2-O'-Me-5′AMP or 100 μM 8-(4-chlorophenylthio)-cAMP were washed from resistant cultures. 1.25×10^7^cells were aliquoted to a 50ml falcon tube and centrifuged at 2000rpm for 10minutes. The supernatant was removed and pellet re-suspended in 50ml fresh 20%HMI-9. Washed cells were incubated at 37°C for a few days, passaging back to 2.5×10^5^cells/ml when necessary; before freezing as above at −80°C.

Genomic DNA extraction {#S10}
----------------------

Genomic DNA was harvested from resistant cultures. After cells were aliquoted for freezing and washing the remaining culture was divided between two falcon tubes, centrifuged at 2000rpm for 10minutes and the supernatant poured off. The pellets were re-suspended, mixed together and the resulting solution divided between six 1.5ml eppendorfs. Genomic DNA was extracted using a Qiagen DNeasy blood and tissue kit into six columns, eluting into 150 μl and stored at −20 °C.

PCR was carried out on genomic DNA from resistant cultures and *Escherichia coli* transformed with pGEM-T-Easy plasmids or the amplicons subject to Ion Torrent™ sequencing. All PCRs were carried out in 0.2ml PCR tubes using the Thermo Electron Corporation SPRINT thermal cycler. Typical 50 μl PCR reaction:10 μl 5xFlexibuffer, 4 μl 2.5 μM dNTPs, 3 μl 25 mM MgCl~2~, 2 μl forward and reverse primers, 0.5 μl Taq polymerase, 0.5 μl DNA sample and 27.5 μl dH~2~O. Typical PCR conditions:95°c for 5minutes, 30 cycles of (95°C for 30 seconds, 55°C for 45seconds and 72°C for 2minutes), followed by 72°C for 4minutes. The primers used are shown below. Lib2\
ForwardTAGCCCCTCGAGGGCCAGTRNAi insert specific: for amplifying\
RNAi inserts from genomic DNALib2\
ReverseGGAATTCGATATCAAGCTTGGCM13\
ForwardGTAAAACGACGGCCAGTGpGEM-T-Easy vector specific: for\
amplifying or sequencing RNAi inserts\
ligated into pGEM-T-EasyM13\
ReverseGGAAACAGCTATGACCATG[^2]

Validation through independent RNAi constructs {#S11}
----------------------------------------------

RNAi target gene fragments were selected based on default settings of the RNAit software^[@R31]^. They were amplified from AnTat 1.1 90:13^[@R32]^ genomic DNA (for pleomorph RNAi lines) using a forward primer carrying flanking BamHI and HindIII or Nde sites and a reverse primer carrying flanking XhoI and XbaI sites for cloning into the stem-loop pALC14 plasmid^[@R33]^. The constructs were linearized with *Not*I and transfected into AnTat 1.1 90:13 cells by electroporation. Stable transfectants were selected in the presence of 1 μg/ml puromycin using the methods described in MacGregor et al.(2013)^[@R34]^

For the monomorph RNAi lines, the target fragments were amplified using forward primer carrying flanking *Xba*I and *Bam*HI and reverse primer carrying *Xho*I and *Sma*I sites for cloning into the stem loop pRPa^iSL^ (MCS 1/2) plasmid^[@R35]^. The constructs were linearised with *Asc*I and transfected into 2T1 cells by electroporation. Stable transfectants were selected in the presence of 2.5 μg/ml hygromycin.

For overexpression of *RBP7B*, the coding region was amplified and inserted into the expression vector pDEX-577-Y ^[@R36]^. Several independent cell lines were isolated and their growth analysed *in vitro* or *in vivo* in the presence or absence of tetracycline, or doxycycline, respectively.

Ion Torrent™ sequencing and bioinformatics analysis {#S12}
---------------------------------------------------

Ion Torrent™ sequencing was carried out at the University of Edinburgh Wellcome Trust Clinical Research Facility Genetics Core. For library preparation, each sample was assigned an Ion Xpress barcode, Xpress Barcode 1 or Xpress barcode 2 and samples were run on a 316D chip, generating 2,801,839 total reads, with each sample (pCPT-cAMP, 8pCPT-2-O'-Me-5′AMP screen outputs) generating \>1.3 million reads.

The quality of raw sequence data was assessed using FastQC (<http://www.bioinformatics.babraham.ac.uk/projects/fastqc/>). Cutadapt software was used to identify and remove primer sequences (parameters: -O 10 -m 25 -n 3 -q 20; version: 1.0); this in effect partitioned the reads into those that had a given primer (e.g. "Lib2F, trimmed") and those that did not (e.g. Lib2F, not trimmed"). Partitioning was done for each primer for each sample. Sequences were aligned to the *Trypanosoma brucei brucei* genome (obtained from [ftp.sanger.ac.uk/pub4/pathogens/Trypanosoma/brucei/Latest_Whole_Genome_Sequence/Tb927_WGS_24_08_2012/chromosomes/](http://ftp.sanger.ac.uk/pub4/pathogens/Trypanosoma/brucei/Latest_Whole_Genome_Sequence/Tb927_WGS_24_08_2012/chromosomes/)) using bowtie2 (parameters: \--very-sensitive; version: 2.0.2), piped through samtools (parameters: -bhS; version: 0.1.18), and stored in indexed BAM format. Read depths were calculated using simple scripts.

The annotated *T. b. brucei* genome was viewed using Artemis software (<http://www.sanger.ac.uk/resources/software/artemis/> ; <http://ukpmc.ac.uk/abstract/MED/11120685>), and coding segment (CDS) region coordinates extracted prior to conversion to bedtools bedfile format using simple scripts. Overlap analyses, to determine reads mapping to CDS regions ("gene-based" tallies), were performed using the "GenomicFeatures" Bioconductor package ([www.bioconductor.org](http://www.bioconductor.org)).

Transcriptome analysis {#S13}
----------------------

Quality of sequence data provided by BGI Hong Kong was assessed using FastQC (<http://www.bioinformatics.babraham.ac.uk/projects/fastqc/>). No additional processing of the primary data was required.

Sequence alignment to the T. brucei brucei genome {#S14}
-------------------------------------------------

Paired end sequences were aligned to the *Trypanosoma brucei* genome (obtained from [ftp.sanger.ac.uk/pub4/pathogens/Trypanosoma/brucei/Latest_Whole_Genome_Sequence/Tb927_WGS_24_08_2012/chromosomes/](http://ftp.sanger.ac.uk/pub4/pathogens/Trypanosoma/brucei/Latest_Whole_Genome_Sequence/Tb927_WGS_24_08_2012/chromosomes/) ) using bowtie2 (parameters: \--very-sensitive-local; version: 2.0.2), piped through samtools (parameters: -bhS; version: 0.1.18), and stored in indexed BAM format.

Alignment to protein-coding regions {#S15}
-----------------------------------

The annotated *T. b. brucei* genome was viewed using Artemis software (<http://www.sanger.ac.uk/resources/software/artemis/> ; <http://ukpmc.ac.uk/abstract/MED/11120685>), and coding segment (CDS) region coordinates extracted prior to conversion to bedfile file format. Bedtools (parameters: multicov -bams ; version: bedtools 2.15.0) was used to generate coverages for each CDS for each sample replicate. RPKM-like values were calculated by dividing coverage by CDS size.

Pair-wise comparisons of the samples {#S16}
------------------------------------

Statistical analyses of the sample groups were undertaken in the R environment using Bioconductor packages. Differential expression was explored using linear models and empirical Bayes methods, using the limma Bioconductor package^[@R37]^. RPKM-like values were offset by 1, and logged. Prior to quantile normalisation and groupwise comparisons, the data were filtered to remove loci whose mean values were below the 10% quantile for all samples.

Northern blotting {#S17}
-----------------

RNA preparation and analysis was carried out as described^[@R38]^

Antibodies {#S18}
----------

Antibodies used in this study were: Anti-EP Procyclin, sourced from Cedar Lane, Canada (cat. no. CLP001A) Anti-PAD1, as detailed in Dean et al, (2009)^[@R26]^

In vitro pCPTcAMP resistance validation {#S19}
---------------------------------------

Pleomorphic cells were seeded at 1 ×10^5^ cells/ml. RNAi was induced in one flask (1 μg/ml doxycycline) while the other was left uninduced. After 24 hours, each flask was split, one being exposed to 100 μM of pCPTcAMP (Sigma). Assays were performed in triplicate, growth being monitored every 24 hours. Cells were maintained at ≤ 1 ×10^6^ cells/ml using HMI-9, supplementing with doxycycline and pCPTcAMP, where needed.

Cell cycle analysis {#S20}
-------------------

Methanol-fixed blood smears were re-hydrated in PBS for 10 min and stained with DAPI (100 ng/ml) for 5 minutes. 250 cells were analysed per slide.

In vitro differentiation to procyclic forms {#S21}
-------------------------------------------

Parasites were incubated at 3 ×10^6^ cells/ml in SDM79 with 6mM cis-aconitate (CCA), 27°C. Samples were collected for flow cytometry at 0-24 hours.

Flow cytometry {#S22}
--------------

Approximately 3 ×10^6^ cells were 2% formaldehyde/0.05% Glutaraldehyde-fixed for \>1 h at 4 °C. Subsequently, the cell suspension was pelleted, washed twice with PBS and re-suspended in 200μl mouse α-EP-procyclin (Cedar Lane, cat. no. CLP001A; 1:500) or rabbit α-PAD1^[@R26]^ (1:100). After washing and staining with secondary antibody (1:1000 α mouse-FITC and α-rabbit-Cy5) cells were analysed using a Becton Dickenson LSRII Flow cytometer and analysed using FlowJO software (Tree Star Inc.). Unstained cells and secondary antibody-only stained cells provided negative controls.

Mitotracker assays {#S23}
------------------

Bloodstream-form trypanosomes (2 ×10^6^ /ml) were incubated in HMI-medium containing 100 nM Mitotracker Red CMXROS (Molecular Probes) for 30 min at 37°C. Then the cells were washed with HMI-9 and incubated for a further 20 min in the absence of Mitotracker, after which the parasites were fixed for 2 min at 4°C with 0.4% paraformaldehyde (prepared fresh in PBS). The cells were then washed once with PBS and air-dried smears were prepared. The slides were fixed for 10 min in methanol at 20°C, before rehydration for 10 min in PBS, followed by DAPI staining and mounting in MOWIOL.

Statistical analyses and animal studies {#S24}
---------------------------------------

Animal experiments were carried out according to the UK Animals (Scientific) Procedures act under a licence (60/4373) issued by the UK Home Office and approved by the University of Edinburgh Local ethical committee.

Animal groups were selected from age and sex matched MF1 mice, with comparisons plus or minus doxycycline carried out on mice from the same batch randomly allocated.

Six female age-matched cyclophosphamide-treated MF1 mice were inoculated i.p. One group (n=3) was provided with doxycycline (200 μg/ml in 5% sucrose) in their drinking water immediately pre-inoculation, the other group (n=3) received 5% sucrose only. Parasitaemias were scored over 5-7 days with humane end-points conforming to UK Home Office requirements.

Three mice per group were used to generate data for statistical analysis. Preliminary analyses suggested that this sample size would be sufficient to detect differences between cell lines and treatment groups (i.e. plus/minus doxycycline). To analyse significance, data was collected on %1K1N values from the test genes and one control (Antat 1.1 90:13) with and without the presence of doxycycline. Blinding was not carried out. Data was analysed with Proc Mixed SAS version 9.3.1, SAS Institute Inc., Cary, NC or Minitab 16 Statistical Software, using using a general linear model (GLM), general linear mixed model (GLMM), or a *X*^2^ test. Data was examined prior to analysis to ensure normality and no transformations were required. P values of less than 0.05 were considered statistically significant. A Bonferroni correction was used for analysis of RNAi cell lines over multiple days ([Figure 3](#F3){ref-type="fig"}), to account for multiple comparisons. No animals were excluded from the analysis, although humane end points were applied at peak parasitaemias for some groups where quorum sensing was lost, causing enhanced virulence.
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![Identification of trypanosome QS regulators\
**a.** Selection for genes whose RNAi silencing renders trypanosomes resistant to pCPTcAMP or 8-pCPT-2′-O-Me-5′-AMP, identifying molecules that promote stumpy formation.\
**b.** RNAi libaries were exposed to pCPTcAMP or 8-pCPT-2′-O-Me-5′-AMP, RNAi being induced (1 μg/ml tetracycline), or not. The curves for uninduced samples are combined for clarity (mean ±s.e.m, n=5).\
**c.** Ion Torrent™ read-density from the selected parasites aligned to the trypanosome genome. Since amplicons were fragmented prior to sequencing, reads with and without the flanking primers are shown.](emss-55604-f0001){#F1}

![RNAi to the identified genes prevents growth control and morphological transformation\
**a.** *In vivo* growth of pleomorphic RNAi lines targeting distinct genes identified from the genome-wide screen for QS-signal resistance. RNAi was induced by provision of doxycyline to the infected animals (n=3, red lines), with parallel infections remaining uninduced (n=3, blue lines). Infections were terminated when the ascending parasitaemias were predicted to become lethal within 12 hours (crosses).\
**b.**Morphology of *PP1* RNAi cells and parental *T. brucei* AnTat1.1 90:13 cells (each grown in mice ±doxycycline) at 6 days post-infection. The induced *PP1* cells remained predominently slender in morphology. Cells with slender (SL), intermediate (INT) or stumpy (ST) morphology are labelled. Bar=15μm.](emss-55604-f0002){#F2}

![Silencing the identified genes reduces G1 arrest and differentiation competence\
**a.** Cell-cycle status of pleomorphic RNAi lines. n=6; mean ±s.e.m. percentage 1 kinetoplast (K), 1 nucleus (N) (G0/G1, plus S-phase cells; left Y-axis), 2K1N (G2-phase cells) or 2K2N (post-mitotic cells) (both right Y-axis) are shown. Test genes showed a signficant difference (GLMM, p\<0.001) in comparison to AnTat1.1 90:13 +doxycycline on at least one day of infection.\
**b.** PAD1 expression on day 6 post-infection (n=3/group, mean ±s.e.m.). *PP1* RNAi cells show reduced *PAD1* expression (GLM, F1,4=22.35, p=0.009).\
**c.** *PP1*-depleted cells show signficantly reduced Procyclin expression during differentiation (GLM, F1,4=10.87, p=0.030) Bars represents mean ±s.e.m; n=3.](emss-55604-f0003){#F3}

![RBP7 drives cell cycle arrest and differentiation competence\
**a.** Inducible overexpression of *RBP7B* mRNA on day 3 post-infection. Stumpy RNA is also shown; Ethidium bromide stained rRNA indicates loading.\
**b.** AnTat1.1 90:13 induced with doxycycline (red lines) to overexpress *RBP7B* show reduced parasitaemia in mice (n=3 per group). GLM, F~1,4~=55.25, p=0.002 and F~1,4~=233.1, p\<0.001 on day 2 and 3, respectively.\
**c.** Cells accumulate in G1 upon *RBP7B* ectopic expression. Values shown are mean ±s.e.m at day 3 post-infection; n=3 per group. GLM, F~1,4~=15.1, p=0.018 (1K1N); F~1,4~=8.9, p=0.041 (2K1N); F~1,4~=5.17, p=0.085 (2K2N).\
**d.** Parasites isolated on day 3 post-infection were exposed to 6mM cis aconitate (CCA) and EP-procyclin expression monitored by flow cytometry. At 0h enhanced cold induction of EP procyclin expression is seen in the induced population. n=3; GLM; F~1,4~=8.54, p=0.043 (0h); F~1,4~=9.99, p=0.034 (4h); F~1,4~=10.36, p=0.032 (6h) F~1,4~=6.84 , p=0.059 (8h).\
**e.** Schematic of the proposed SIF-signaling pathway in *T. brucei*. Major identified components ([Supp. Table 2](#SD7){ref-type="supplementary-material"}) are shown; those in bold italics are experimentally confirmed. The order and potential branching in the pathway is unknown as is the position of pathway inhibitors, *TbTOR4* (Tb927.1.1930) *ZFK* (Tb927.11.9270) and *MAPK5* (Tb927.6.4220).](emss-55604-f0004){#F4}
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